Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Legacy Salmon Creek Hospital
mi
from
Vancouver, WA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Legacy Salmon Creek Hospital
mi
from
Vancouver, WA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Licking Memorial Hospital
mi
from
Newark, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Littleton Adventist Hospital
mi
from
Littleton, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Littleton Adventist Hospital
mi
from
Littleton, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Longmont United Hospital
mi
from
Longmont, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Marie Yeager Cancer Center
mi
from
Saint Joseph, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Marie Yeager Cancer Center
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Marietta Memorial Hospital
mi
from
Marietta, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Martin Hospital South
mi
from
Stuart, FL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Martin Hospital South
mi
from
Stuart, FL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Martin Medical Center
mi
from
Stuart, FL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Martin Medical Center
mi
from
Stuart, FL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
McKee Medical Center
mi
from
Loveland, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
McLeod Regional Medical Center
mi
from
Florence, SC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
McLeod Regional Medical Center
mi
from
Florence, SC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Memorial Medical Center
mi
from
Springfield, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Menorah Medical Center
mi
from
Overland Park, KA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Menorah Medical Center
mi
from
Overland Park, KA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Hospital
mi
from
Coon Rapids, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Hospital Springfield
mi
from
Springfield, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Hospital Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Hospital-Joplin
mi
from
Joplin, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Hospital-Joplin
mi
from
Joplin, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Medical Center
mi
from
Durango, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Medical Center
mi
from
Durango, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Methodist Medical Center of Illinois
mi
from
Peoria, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Michiana Hematology-Oncology
mi
from
Elkhart, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Michiana Hematology-Oncology
mi
from
Elkhart, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Michiana Hematology Oncology PC-Mishawaka
mi
from
Mishawaka, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Michiana Hematology Oncology PC-Mishawaka
mi
from
Mishawaka, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Michiana Hematology Oncology
mi
from
Plymouth, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Michiana Hematology Oncology
mi
from
Plymouth, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Michiana Hematology Oncology
mi
from
South Bend, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Michiana Hematology Oncology
mi
from
South Bend, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Michiana Hematology Oncology-PC Westville
mi
from
Westville, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Michiana Hematology Oncology-PC Westville
mi
from
Westville, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mid-Michigan Medical Center - Midland
mi
from
Midland, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mid-Michigan Medical Center - Midland
mi
from
Midland, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Middlesex Hospital
mi
from
Middletown, CT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Middlesex Hospital
mi
from
Middletown, CT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Nebraska Cancer Research Center
mi
from
Lincoln, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Nebraska Cancer Research Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
New Ulm Medical Center
mi
from
New Ulm, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
North Colorado Medical Center
mi
from
Greeley, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
North Kansas City Hospital
mi
from
Kansas City, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
North Kansas City Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Pacific Medical Center-First Hill
mi
from
Seattle, WA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Pacific Medical Center-First Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Park Ridge Hospital Breast Health Center
mi
from
Hendersonville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Park Ridge Hospital Breast Health Center
mi
from
Hendersonville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Parker Adventist Hospital
mi
from
Parker, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Parker Adventist Hospital
mi
from
Parker, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
PeaceHealth Southwest Medical Center
mi
from
Vancouver, WA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
PeaceHealth Southwest Medical Center
mi
from
Vancouver, WA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Penrose-Saint Francis Healthcare
mi
from
Colorado Springs, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Penrose-Saint Francis Healthcare
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Phelps County Regional Medical Center
mi
from
Rolla, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Phelps County Regional Medical Center
mi
from
Rolla, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Phoenixville Hospital
mi
from
Phoenixville, PA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Phoenixville Hospital
mi
from
Phoenixville, PA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Porter Adventist Hospital
mi
from
Denver, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Poudre Valley Hospital
mi
from
Fort Collins, CO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Poudre Valley Hospital
mi
from
Fort Collins, CO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Presbyterian Intercommunity Hospital
mi
from
Whittier, CA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Presbyterian Intercommunity Hospital
mi
from
Whittier, CA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Presbyterian Kaseman Hospital
mi
from
Albuquerque, NM
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Presbyterian Kaseman Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Princeton Community Hospital
mi
from
Princeton, WV
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Princeton Community Hospital
mi
from
Princeton, WV
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Proctor Hospital
mi
from
Peoria, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Proctor Hospital
mi
from
Peoria, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Providence Hospital,
mi
from
Mobile, AL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Providence Hospital,
mi
from
Mobile, AL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Providence Medical Center
mi
from
Kansas City, KA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Providence Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials